Comprehensive Report: Personalized Medicine in Cancer - A Review
VerifiedAdded on 2022/12/27
|1
|772
|43
Report
AI Summary
This report provides a comprehensive overview of personalized medicine in cancer, emphasizing its basis in genetic characteristics and specific diseases. It discusses targeted therapies, such as those used for HER2-positive breast cancer, and the importance of understanding gene-drug interactions (pharmacogenomics). The report addresses ethical considerations, including incidental findings and the need for standard treatment guidelines. It highlights precision medicine approaches, where treatments are selected based on genetic understanding, and the importance of considering patient medical history and potential adverse effects. The report concludes that personalized medicine offers newer treatments that target abnormal proteins or mutated genes, potentially leading to improved cancer prevention and treatment outcomes. It also references studies and the role of ethical issues in the field.






